Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Total Revenue | 5.0M | 1.5M | 1.9M | 2.1M | 1.8M | -- |
| Operating Revenue | 5.0M | 1.5M | 1.9M | 2.1M | 1.8M | -- |
| Cost Of Revenue | 3.9M | 1.0M | 1.7M | 1.9M | 1.3M | -- |
| Gross Profit | 1.1M | 466,963 | 215,396 | 222,669 | 465,138 | -- |
| Selling General And Administration | 540,179 | 508,852 | 517,486 | 852,986 | 314,217 | -- |
| General And Administrative Expense | 499,053 | 462,846 | 407,877 | 749,489 | 279,082 | -- |
| Depreciation And Amortization In Income Statement | 9,856 | 9,624 | 9,624 | 24,705 | 10,300 | -- |
| Other Operating Expenses | 10,427 | 21,403 | 6,799 | 9,812 | 6,074 | -- |
| Operating Expense | 560,462 | 539,879 | 533,909 | 887,503 | 330,591 | -- |
| Operating Income | 558,965 | -72,916 | -318,513 | -664,834 | 134,547 | -- |
| EBIT | 558,965 | -72,916 | -318,513 | -664,834 | 134,547 | -- |
| Other Income Expense | 580,800 | -164,875 | 650,491 | -413,363 | 2,828 | -- |
| Other Non Operating Income Expenses | 40,721 | 7,921 | 4,294 | 201,778 | 16,170 | -- |
| Special Income Charges | 0.00 | -123,810 | 19,652 | -255,291 | 76,902 | -- |
| Write Off | 0.00 | 123,810 | -- | 68,523 | -76,902 | 0.00 |
| Gain On Sale Of Security | 540,079 | -48,986 | 626,545 | -359,850 | -90,244 | -- |
| Pretax Income | 1.1M | -237,791 | 331,978 | -691,671 | 137,375 | -- |
| Tax Effect Of Unusual Items | 81,012 | 0.00 | 96,930 | 0.00 | -2,001 | -- |
| Net Income From Continuing And Discontinued Operation | 1.1M | -237,792 | 331,978 | -691,671 | 137,375 | -- |
| Net Income From Continuing Operation Net Minority Interest | 1.1M | -237,792 | 331,978 | -691,671 | 137,375 | -- |
| Net Income Including Noncontrolling Interests | 1.1M | -237,791 | 331,978 | -691,671 | 137,375 | -- |
| Net Income Common Stockholders | 1.1M | -237,792 | 331,978 | -691,671 | 137,375 | -- |
| Net Income | 1.1M | -237,792 | 331,978 | -691,671 | 137,375 | -- |
| EBITDA | 605,055 | -29,195 | -272,958 | -593,046 | 181,135 | -- |
| Normalized EBITDA | 64,976 | 143,601 | -919,155 | 22,095 | 194,477 | -- |
| Reconciled Depreciation | 46,090 | 43,721 | 45,555 | 71,788 | 46,588 | -- |
| Basic EPS | 0.01 | 0.00 | 0.00 | -- | 0.00 | 0.00 |
| Diluted EPS | 0.01 | 0.00 | 0.00 | -- | 0.00 | 0.00 |
| Basic Average Shares | 115.1M | 115.1M | 115.1M | -- | 115.1M | 115.1M |
| Diluted Average Shares | 115.1M | 115.1M | 115.1M | -- | 115.1M | 115.1M |
| Total Unusual Items | 540,079 | -172,796 | 646,197 | -615,141 | -13,342 | -- |
| Total Unusual Items Excluding Goodwill | 540,079 | -172,796 | 646,197 | -615,141 | -13,342 | -- |
| Tax Rate For Calcs | 0.15 | 0.00 | 0.15 | 0.00 | 0.15 | -- |
| Normalized Income | 680,699 | -64,996 | -217,289 | -76,530 | 148,716 | -- |
| Depreciation Amortization Depletion Income Statement | 9,856 | 9,624 | 9,624 | 24,705 | 10,300 | -- |
| Depreciation Income Statement | 9,856 | 9,624 | 9,624 | 24,705 | 10,300 | -- |
| Diluted NI Availto Com Stockholders | 1.1M | -237,792 | 331,978 | -691,671 | 137,375 | -- |
| Gain On Sale Of Ppe | 0.00 | 0.00 | 19,652 | 10,539 | 0.00 | -- |
| Impairment Of Capital Assets | 0.00 | 0.00 | 0.00 | 197,307 | 0.00 | -- |
| Net Income Continuous Operations | 1.1M | -237,791 | 331,978 | -691,671 | 137,375 | -- |
| Other Gand A | 379,066 | 461,536 | 371,034 | -275,767 | 277,771 | -- |
| Reconciled Cost Of Revenue | 3.8M | 992,674 | 1.7M | 1.8M | 1.3M | -- |
| Salaries And Wages | 119,987 | 1,310 | 36,843 | 1.0M | 1,311 | -- |
| Selling And Marketing Expense | 41,126 | 46,006 | 109,609 | 103,497 | 35,135 | -- |
| Total Expenses | 4.4M | 1.6M | 2.2M | 2.8M | 1.6M | -- |
| Total Operating Income As Reported | -- | -61,982 | -- | -- | -- | -43,071 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | 8.1M | 7.5M | 8.0M | 8.1M | 9.0M | -- |
| Cash Cash Equivalents And Short Term Investments | 10.6M | 9.4M | 9.9M | 9.5M | 10.3M | -- |
| Other Short Term Investments | 2.5M | 1.9M | 2.0M | 1.4M | 1.3M | -- |
| Accounts Receivable | 1.3M | 876,205 | 515,169 | 458,711 | 1.0M | -- |
| Receivables | 1.6M | 1.2M | 709,066 | 631,947 | 1.1M | -- |
| Prepaid Assets | 278,965 | 338,301 | 52,353 | 133,286 | 93,171 | -- |
| Other Current Assets | -- | -- | -- | -- | 1.00 | -- |
| Current Assets | 12.4M | 11.0M | 10.7M | 10.2M | 11.4M | -- |
| Gross PPE | 6.2M | 6.1M | 6.0M | 5.9M | 6.1M | -- |
| Accumulated Depreciation | -1.7M | -1.7M | -1.7M | -1.7M | -1.6M | -- |
| Net PPE | 4.5M | 4.4M | 4.3M | 4.3M | 4.5M | -- |
| Other Non Current Assets | 241,124 | 249,799 | 189,852 | 213,512 | 211,737 | -- |
| Total Non Current Assets | 4.7M | 4.7M | 4.5M | 4.5M | 4.8M | -- |
| Total Assets | 17.2M | 15.7M | 15.2M | 14.7M | 16.2M | -- |
| Accounts Payable | 986,506 | 408,654 | 615,394 | 332,547 | 321,578 | -- |
| Payables | 986,506 | 408,654 | 615,394 | 332,547 | 321,578 | -- |
| Payables And Accrued Expenses | 986,506 | 408,654 | 615,394 | 332,547 | 321,578 | -- |
| Current Deferred Revenue | 55,956 | 55,956 | 55,956 | 55,956 | 55,956 | -- |
| Current Liabilities | 2.2M | 1.9M | 1.2M | 1.0M | 1.9M | -- |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Total Liabilities Net Minority Interest | 2.2M | 1.9M | 1.2M | 1.0M | 1.9M | -- |
| Common Stock | 20.2M | 20.2M | 20.2M | 20.2M | 20.2M | -- |
| Capital Stock | 20.2M | 20.2M | 20.2M | 20.2M | 20.2M | -- |
| Additional Paid In Capital | 5.6M | 5.4M | 5.4M | 5.4M | 5.4M | -- |
| Retained Earnings | -10.8M | -11.9M | -11.7M | -12.0M | -11.3M | -- |
| Common Stock Equity | 15.0M | 13.8M | 14.0M | 13.7M | 14.3M | -- |
| Stockholders Equity | 15.0M | 13.8M | 14.0M | 13.7M | 14.3M | -- |
| Total Equity Gross Minority Interest | 15.0M | 13.8M | 14.0M | 13.7M | 14.3M | -- |
| Total Capitalization | 15.0M | 13.8M | 14.0M | 13.7M | 14.3M | -- |
| Net Tangible Assets | 15.0M | 13.8M | 14.0M | 13.7M | 14.3M | -- |
| Tangible Book Value | 15.0M | 13.8M | 14.0M | 13.7M | 14.3M | -- |
| Working Capital | 10.3M | 9.1M | 9.5M | 9.2M | 9.6M | -- |
| Invested Capital | 15.0M | 13.8M | 14.0M | 13.7M | 14.3M | -- |
| Share Issued | 115.1M | 115.1M | 115.1M | 115.1M | 115.1M | -- |
| Ordinary Shares Number | 115.1M | 115.1M | 115.1M | 115.1M | 115.1M | -- |
| Allowance For Doubtful Accounts Receivable | -341,013 | -341,013 | -378,231 | -378,231 | -302,371 | -- |
| Buildings And Improvements | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | -- |
| Current Deferred Liabilities | 1.2M | 1.5M | 598,951 | 708,672 | 1.5M | -- |
| Duefrom Related Parties Current | 12,235 | 1,793 | 8,616 | 8,840 | 0.00 | -- |
| Gross Accounts Receivable | 1.7M | 1.2M | 893,400 | 836,942 | 1.3M | -- |
| Land And Improvements | 298,856 | 298,856 | 298,856 | 298,856 | 298,856 | -- |
| Machinery Furniture Equipment | 1.6M | 1.6M | 1.6M | 1.6M | 1.5M | -- |
| Other Properties | 3.3M | 3.2M | 3.0M | 3.0M | 3.3M | -- |
| Other Receivables | 51,829 | 116,305 | 44,375 | 45,587 | 44,198 | -- |
| Taxes Receivable | 225,628 | 200,270 | 140,906 | 118,809 | 0.00 | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 649,465 | -131,215 | -135,521 | -1.5M | 1.4M | -- |
| Cash Flow From Continuing Operating Activities | 649,465 | -131,215 | -135,521 | -1.5M | 1.4M | -- |
| Depreciation And Amortization | 46,090 | 43,721 | 45,555 | 71,788 | 46,588 | -- |
| Depreciation Amortization Depletion | 46,090 | 43,721 | 45,555 | 71,788 | 46,588 | -- |
| Stock Based Compensation | 119,986 | 1,311 | 1,310 | 11,343 | 1,311 | -- |
| Change In Working Capital | -59,880 | -27,715 | 64,037 | -1.1M | 1.1M | -- |
| Changes In Account Receivables | -379,853 | -432,966 | -175,246 | 507,085 | 91,172 | -- |
| Change In Receivables | -390,295 | -426,143 | -175,022 | -288,298 | 786,555 | -- |
| Change In Payables And Accrued Expense | 577,852 | -206,740 | 282,847 | 37,645 | 513.00 | -- |
| Change In Payable | 577,852 | -206,740 | 282,847 | 37,645 | 513.00 | -- |
| Other Non Cash Items | -- | -- | -- | 188,433 | 0.00 | 0.00 |
| Capital Expenditure | -13,896 | -- | -178,282 | -314,452 | -- | -69,179 |
| Purchase Of PPE | -13,896 | -10,439 | -92,255 | -71,221 | 0.00 | -- |
| Net PPE Purchase And Sale | -13,896 | -10,439 | -54,255 | -59,317 | 0.00 | -- |
| Purchase Of Investment | -130,590 | -7.00 | -6,686 | -188,476 | 0.00 | -- |
| Sale Of Investment | 157,427 | 0.00 | 104,412 | 57,361 | 1.00 | -- |
| Net Investment Purchase And Sale | 26,837 | -7.00 | 97,726 | -131,115 | 1.00 | -- |
| Investing Cash Flow | -84,814 | -296,952 | -17,732 | 676,941 | -276,888 | -- |
| Cash Flow From Continuing Investing Activities | -84,813 | -296,952 | -17,732 | 676,940 | -276,888 | -- |
| Repayment Of Debt | -- | -- | -- | 0.00 | 0.00 | 0.00 |
| Net Issuance Payments Of Debt | -- | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance Of Capital Stock | -- | -- | -- | 0.00 | -- | -- |
| Net Common Stock Issuance | -- | -- | -- | 0.00 | -- | -- |
| Financing Cash Flow | 0.00 | -- | -- | 0.00 | 0.00 | 0.00 |
| Cash Flow From Continuing Financing Activities | 0.00 | -- | -- | 0.00 | 0.00 | 0.00 |
| Changes In Cash | 564,651 | -428,167 | -153,253 | -843,254 | 1.1M | -- |
| Beginning Cash Position | 7.5M | 8.0M | 8.1M | 9.0M | 7.8M | -- |
| End Cash Position | 8.1M | 7.5M | 8.0M | 8.1M | 9.0M | -- |
| Free Cash Flow | 635,569 | -55,627 | -313,803 | -1.8M | 1.4M | -- |
| Asset Impairment Charge | 0.00 | 0.00 | 0.00 | 265,830 | -76,902 | -- |
| Capital Expenditure Reported | -- | -- | -86,027 | -- | -- | -- |
| Change In Account Payable | 577,852 | -206,740 | 282,847 | 37,645 | 513.00 | -- |
| Change In Prepaid Assets | -247,437 | 605,168 | -43,788 | -858,125 | 319,745 | -- |
| Common Stock Issuance | -- | -- | -- | 0.00 | -- | -- |
| Depreciation | 46,090 | 43,721 | 45,555 | 71,788 | 46,588 | -- |
| Gain Loss On Investment Securities | -93,283 | -948.00 | 281,142 | 303,114 | -54,326 | -- |
| Gain Loss On Sale Of Business | -- | -- | -- | 0.00 | 0.00 | -- |
| Gain Loss On Sale Of PPE | 0.00 | 0.00 | -19,652 | -341,194 | 0.00 | -- |
| Long Term Debt Payments | -- | -- | -- | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | 1.1M | -237,791 | 331,978 | -691,671 | 137,375 | -- |
| Net Long Term Debt Issuance | -- | -- | -- | 0.00 | 0.00 | 0.00 |
| Net Other Investing Changes | -97,755 | -372,533 | 24,824 | 1.1M | -276,889 | -- |
| Operating Gains Losses | -93,283 | -948.00 | 261,490 | -38,080 | -54,326 | -- |
| Proceeds From Stock Option Exercised | -- | -- | -- | 0.00 | 0.00 | -- |
| Sale Of PPE | 0.00 | 0.00 | 38,000 | 11,904 | 0.00 | -- |
| Unrealized Gain Loss On Investment Securities | -406,964 | 90,207 | -839,891 | -- | 227,587 | -104,300 |